144 related articles for article (PubMed ID: 29196927)
1. Characteristics of cerebellar glioblastomas in adults.
Picart T; Barritault M; Berthillier J; Meyronet D; Vasiljevic A; Frappaz D; Honnorat J; Jouanneau E; Poncet D; Ducray F; Guyotat J
J Neurooncol; 2018 Feb; 136(3):555-563. PubMed ID: 29196927
[TBL] [Abstract][Full Text] [Related]
2. Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.
Tauziède-Espariat A; Saffroy R; Pagès M; Pallud J; Legrand L; Besnard A; Lacombe J; Lot G; Borha A; Tazi S; Adle-Biassette H; Polivka M; Lechapt E; Varlet P
Clin Neuropathol; 2018; 37(5):209-216. PubMed ID: 29809131
[TBL] [Abstract][Full Text] [Related]
3. Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With Prognosis.
Picart T; Poncet D; Barritault M; Bauchet L; Zouaoui S; Guyotat J; Gabut M; Fina F; Honnorat J; Figarella-Branger D; Pallud J; Ducray F; Meyronet D; ;
Am J Surg Pathol; 2023 Jan; 47(1):131-144. PubMed ID: 36418240
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
[TBL] [Abstract][Full Text] [Related]
6. The impact of TP53 and RAS mutations on cerebellar glioblastomas.
Milinkovic VP; Skender Gazibara MK; Manojlovic Gacic EM; Gazibara TM; Tanic NT
Exp Mol Pathol; 2014 Oct; 97(2):202-7. PubMed ID: 25036404
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations.
Shibahara I; Sonoda Y; Suzuki H; Mayama A; Kanamori M; Saito R; Suzuki Y; Mashiyama S; Uenohara H; Watanabe M; Kumabe T; Tominaga T
Brain Tumor Pathol; 2018 Jan; 35(1):10-18. PubMed ID: 29138945
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes.
Labussière M; Boisselier B; Mokhtari K; Di Stefano AL; Rahimian A; Rossetto M; Ciccarino P; Saulnier O; Paterra R; Marie Y; Finocchiaro G; Sanson M
Neurology; 2014 Sep; 83(13):1200-6. PubMed ID: 25150284
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in adult cerebellar glioblastoma.
Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
[TBL] [Abstract][Full Text] [Related]
10. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
11. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.
Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A
Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431
[TBL] [Abstract][Full Text] [Related]
12. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.
Kleinschmidt-DeMasters BK; Mulcahy Levy JM
Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845
[TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutations in primary and secondary glioblastomas.
Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H
Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and pathogenesis of cerebellar glioblastoma.
Takahashi Y; Makino K; Nakamura H; Hide T; Yano S; Kamada H; Kuratsu J
Mol Med Rep; 2014 Nov; 10(5):2383-8. PubMed ID: 25199771
[TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
[TBL] [Abstract][Full Text] [Related]
16. Biomarker-based prognostic stratification of young adult glioblastoma.
Zhang RQ; Shi Z; Chen H; Chung NY; Yin Z; Li KK; Chan DT; Poon WS; Wu J; Zhou L; Chan AK; Mao Y; Ng HK
Oncotarget; 2016 Jan; 7(4):5030-41. PubMed ID: 26452024
[TBL] [Abstract][Full Text] [Related]
17. Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.
Picart T; Meyronet D; Pallud J; Dumot C; Metellus P; Zouaoui S; Berhouma M; Ducray F; Bauchet L; Guyotat J; ;
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1843-1856. PubMed ID: 33399987
[TBL] [Abstract][Full Text] [Related]
18. H3K27M mutation in adult cerebellar glioblastoma.
Lu VM; Akinduro OO; Daniels DJ
J Clin Neurosci; 2020 Jan; 71():316-317. PubMed ID: 31843430
[TBL] [Abstract][Full Text] [Related]
19. OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM).
Zhou J; Shi LF; Wang Z; Li M; Zhang JS; Mao Y; Hua W
Clinics (Sao Paulo); 2023; 78():100120. PubMed ID: 37001387
[TBL] [Abstract][Full Text] [Related]
20. Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters.
Nakae S; Murayama K; Sasaki H; Kumon M; Nishiyama Y; Ohba S; Adachi K; Nagahisa S; Hayashi T; Inamasu J; Abe M; Hasegawa M; Hirose Y
J Neurooncol; 2017 Jan; 131(2):403-412. PubMed ID: 27837434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
